O

Oblique Therapeutics

23 employees

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
pain
Health Care
antibody
advanced cancer
drug development
Medical
Hospital
Pharmaceutical
biotech

Date founded

2015

Funding rounds raised

Total raised

$2.5M

from 1 investors over 1 rounds

O

Oblique Therapeutics raised $2.5M on December 11, 2015

Investors: Almi Invest

FAQ